InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,598.40
(
1.03%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.35
(
0.26%
)
Bitcoin
63,461.36
(
-0.84%
)
Post# of 251730
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dewophile

Send PM Follow Ignore
Followers 44
Posts 4531
Boards Moderated 0
Alias Born 07/19/2006

dewophile

Re: ciotera post# 219609

Wednesday, 08/15/2018 8:34:17 AM

Wednesday, August 15, 2018 8:34:17 AM

Post# of 251730

I think the biggest disruptive potential is with long-acting therapies.



Top line results from the first of these studies are in:

https://www.gsk.com/en-gb/media/press-releases/viiv-healthcare-reports-positive-48-week-results-for-first-pivotal-phase-iii-study-for-novel-long-acting-injectable-hiv-treatment-regimen/
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up